Pharma teams, agencies, and data partners

How Pharma Commercial and Brand Teams Are Organized

How pharma commercial organizations are structured: brand teams, omnichannel, media, access, sales, analytics, and where agencies plug in.

Christian Guerrero Published 3 min read Part 1 of 10

The short answer

A pharma commercial organization usually groups work around brands. A brand team led by a brand director owns strategy and budget, with managers for HCP and patient marketing. Around it sit omnichannel and media teams, market access, sales and field operations, analytics, and marketing operations, with medical and regulatory reviewers as partners rather than reports. Agencies and data partners connect mainly through brand and media leads, so clear roles and a shared plan decide how well the whole system works.

From outside, a pharma company looks like one client. Inside, a single campaign involves a brand team, a media team, market access, sales operations, analytics, medical reviewers, legal, privacy, procurement, and several agencies. Understanding who does what makes partners more effective and plans more realistic.

The typical structure

Team Main responsibility
Brand team Strategy, positioning, budget, HCP and patient marketing plans
Omnichannel or customer engagement Channel orchestration, CRM, email, journeys
Media (central or embedded) Media strategy, agency management, investment
Market access Payer strategy, coverage, pull-through
Sales and field operations Rep deployment, targeting, CRM
Analytics and insights Forecasting, measurement, research
Marketing operations Content workflow, review submission, vendor management
Medical affairs Scientific exchange, medical information (separate from promotion)
Legal, regulatory, compliance Review and approval, policy
Privacy and procurement Data use approval, contracts

Common models

  • Brand-led: each brand runs its own media and agencies.
  • Center of excellence: a central team sets standards, owns key partners, and supports brands.
  • Hybrid: central capabilities with brand-level decisions.

The pharma commercial model article covers how field, digital, and media roles fit, and the media operating model guide compares brand-agency-partner structures.

Where agencies and partners connect

Partner Main contacts
Creative agency Brand team, marketing operations
Media agency Media lead, brand team
Data and identity partners Media lead, analytics, privacy
Measurement partners Analytics, media lead
Point-of-care and endemic publishers Media agency, brand team

A RACI clarifies who decides what.

Annual rhythm

  1. Brand planning (often mid-year for next year).
  2. Budget approval.
  3. Agency briefs and plans.
  4. Review and production.
  5. Launch and in-flight optimization.
  6. Quarterly business reviews. See QBR agenda.

What partners should know

  • Decisions often need several functions; plan time for that.
  • Review timelines are real constraints.
  • Analytics teams own the measurement truth; align with them early.
  • Procurement and privacy can delay contracts; start early.

Common mistakes

  • Partners talking only to one contact and missing other decision makers.
  • Brand and media teams with different success metrics.
  • Medical reviewers brought in late.
  • No shared plan across agencies.

Practical takeaway

Partners: ask your client contact for the brand's org chart and RACI at kickoff. Clients: share them. Most delays in pharma programs come from a decision maker nobody knew was involved.

Frequently asked questions

Who leads a pharma brand team?

Usually a brand director or brand lead, reporting to a franchise or business unit head, with product managers for HCP and patient marketing.

Is medical affairs part of the brand team?

No. Medical affairs is separate to keep scientific activity independent of promotion. It partners with brand teams and reviews materials.

Where do media and omnichannel teams sit?

It varies. Some companies have central omnichannel or media centers of excellence; others embed media leads in brand teams.

Sources

External guidance and platform documentation change. Links were current at publication; check them again before relying on them for a decision.

Editorial note. Analysis and frameworks are the author's own and do not represent Acxiom or any current or former employer, client, or named platform. Examples labeled hypothetical or illustrative are not results from real campaigns. Nothing here is legal, regulatory, or medical advice.

Working through this decision on a real plan?

I work on health and pharma data, identity, and activation, after five years running HCP and DTC programmatic agency-side. Happy to talk through how this applies to your situation.